CBDA Research
MB-231: Breast Cancer
MB-231: Breast Cancer
MB-231: Breast Cancer
Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration
COX2: Inflammation
MB-231: Breast Cancer
MB-231: Breast Cancer
Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis
5-HT1A: nausea
5-HT1A: nausea
5-HT1A: nausea
Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation
Rett syndrome
5-HT1A: nausea
5-HT1A: nausea
Chronic treatment with cannabidiolic acid (CBDA) reduces thermal pain sensitivity in male mice and rescues the hyperalgesia in a mouse model of Rett syndrome
Copyright © 2020 NeXtraction - All Rights Reserved.
Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
This website is not intended to provide medical information and does not claim to cure or treat any disease. Always speak to your doctor about health concerns.
Powered by GoDaddy